Please login to the form below

Not currently logged in
Email:
Password:

Valeant completes AB Sanitas purchase

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m

Canada-based Valeant Pharmaceuticals International has completed the acquisition of AB Sanitas in a deal worth €314m.

Announced in May 2011, the deal will see Valeant take full control of the Lithuania-based speciality pharmaceutical firm, gaining 390 generic products in nine Central and Eastern European countries.

Valeant has made several acquisitions in 2011, including the February purchase of privately held firm PharmaSwiss for €350m. This was followed in July by the acquisition of Sanofi's Dermik dermatology unit for $425m.

At the end of July 2011, Valeant was rumoured to be considering making a bid for Sweden-based Meda, and in August 2011, The Wall Street Journal reported Valeant was to purchase dermatological specialists Medicis.

22nd August 2011

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

patients
Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Paris
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...

Infographics